Upadacitinib Tablets (Rematib) – Eczema & Autoimmune Treatment:
Upadacitinib is one of the most powerful JAK inhibitors, primarily used for moderate–severe eczema (atopic dermatitis). It blocks JAK1 signaling that triggers chronic inflammation and allergic flares.
Uses
-
Eczema (Atopic Dermatitis) – FDA-approved
-
Rheumatoid & Psoriatic Arthritis
-
UC & Crohn’s Disease (select cases)
Benefits
-
Very fast itch relief
-
Reduces eczema flare-ups
-
Improves skin barrier recovery
-
Works when steroids or dupilumab fail.
FAQs
Q1. Is Upadacitinib good for eczema?
Yes — one of the best oral options for severe atopic dermatitis.
Q2. How fast does it work?
Many patients see improvement within 7–14 days.
Q3. Can it treat vitiligo or psoriasis?
Limited evidence; not commonly used.
